CD44 and colorectal carcinoma: Although further studies are needed to identify the biomarkers in PLF EVs that may have a role as prognosticators of peritoneal carcinomatosis, our findings demonstrate that the PLF MCs of CRC patients are reactive cells, expressing CD44 on their membrane and releasing EVs that support remodeling of the peritoneal environment.